{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:13:25Z","timestamp":1792260805520,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178182","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:00:15Z","timestamp":1758254415000},"page":"178182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Forskolin alleviates cholestatic liver disease by inhibiting the Hippo\/YAP-mediated ductular reaction and fibrosis progression"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-3510","authenticated-orcid":false,"given":"Walaa H.","family":"El-Maadawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-4309","authenticated-orcid":false,"given":"Ehab","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman A.","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8921-5221","authenticated-orcid":false,"given":"Nesma S.","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed W.","family":"Lethy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"El-Ahwany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-4458","authenticated-orcid":false,"given":"Marwa","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178182_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050407","article-title":"The role of YAP and TAZ in angiogenesis and vascular mimicry","volume":"8","author":"Azad","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.178182_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.25769","article-title":"Yes-associated protein regulates the hepatic response after bile duct ligation","volume":"56","author":"Bai","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178182_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188087","article-title":"Combination of verteporfin-photodynamic therapy with 5-aza-2\u2019-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer","volume":"14","author":"Banerjee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178182_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00005344-199007000-00013","article-title":"Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy - a comparative study with dobutamine and sodium nitroprusside","volume":"16","author":"Baumann","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178182_bib6","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1093\/nar\/gkac624","article-title":"Decoding YAP dependent transcription in the liver","volume":"50","author":"Biagioni","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178182_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121982","article-title":"RGD density along with substrate stiffness regulate hPSC hepatocyte functionality through YAP signalling","volume":"293","author":"Blackford","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2025.178182_bib8","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2025.178182_bib9","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/bph.13611","article-title":"Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats","volume":"173","author":"El-Agroudy","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178182_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxlet.2021.04.018","article-title":"The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and wnt pathways","volume":"347","author":"Esmail","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2025.178182_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41575-019-0156-4","article-title":"Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases","volume":"16","author":"Fabris","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178182_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01191-9","article-title":"The hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178182_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41551-020-0583-0","article-title":"Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma","volume":"4","author":"Gao","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ejphar.2025.178182_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/bph.13766","article-title":"The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy","volume":"174","author":"Ge","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178182_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-022-01906-7","article-title":"Roles of ursodeoxycholic acid in the bile biochemistry and metabolomics in patients with choledocholithiasis: a prospective study","volume":"18","author":"Guan","year":"2022","journal-title":"Metabolomics"},{"key":"10.1016\/j.ejphar.2025.178182_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/toxics12100701","article-title":"Endocrine-disruptive effects of adenylate cyclase activator forskolin: in vitro and in vivo evidence","volume":"12","author":"Huang","year":"2024","journal-title":"Toxics"},{"key":"10.1016\/j.ejphar.2025.178182_bib18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/2211-5463.13596","article-title":"Reversine attenuates cholestatic ductular reaction in rats","volume":"13","author":"Huang","year":"2023","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejphar.2025.178182_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1023684503883","article-title":"Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling","volume":"23","author":"Insel","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178182_bib20","article-title":"Central role for cholangiocyte pathobiology in cholestatic liver diseases","author":"Jalan-Sakrikar","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2015.08.011","article-title":"Liver transplantation for cholestatic liver diseases in adults","volume":"20","author":"Khungar","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.178182_bib22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/emboj.2013.102","article-title":"cAMP\/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes","volume":"32","author":"Kim","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2025.178182_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-pathmechdis-012419-032824","article-title":"Liver progenitors and adult cell plasticity in hepatic injury and repair: knowns and unknowns","volume":"15","author":"Ko","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2025.178182_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.29540","article-title":"C\/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2025.178182_bib27","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41401-021-00754-w","article-title":"Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation","volume":"42","author":"Lu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.178182_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"Meng","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.178182_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0041-1742277","article-title":"Role of YAP1 signaling in biliary development, repair, and disease","volume":"42","author":"Molina","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.178182_bib30","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2025.178182_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejphar.2025.178182_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ejphar.2025.178182_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","article-title":"Liver regeneration requires Yap1-TGF\u03b2-dependent epithelial-mesenchymal transition in hepatocytes","volume":"69","author":"Oh","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178182_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cld.894","article-title":"The pathophysiology of cholestasis and its relevance to clinical practice","volume":"15","author":"Onofrio","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.178182_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.36922\/gpd.0658","article-title":"Verteporfin induces YAP-Dependent cell cycle arrest and caspase-mediated cellular apoptosis in triple-negative breast cancer cells","volume":"2","author":"Parambil","year":"2023","journal-title":"Gene Protein Dis"},{"key":"10.1016\/j.ejphar.2025.178182_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5483\/BMBRep.2018.51.3.016","article-title":"Hippo-YAP\/TAZ signaling in angiogenesis","volume":"51","author":"Park","year":"2018","journal-title":"BMB Rep."},{"key":"10.1016\/j.ejphar.2025.178182_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-024-09868-w","article-title":"Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells","volume":"51","author":"Park","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2025.178182_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-022-00235-5","article-title":"Role of the hippo pathway in liver regeneration and repair: recent advances","volume":"42","author":"Pibiri","year":"2022","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.ejphar.2025.178182_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcp.2019.06.009","article-title":"Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis","volume":"168","author":"Razori","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178182_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","article-title":"Hippo signalling in the liver: role in development, regeneration and disease","volume":"19","author":"Russell","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178182_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/app9194089","article-title":"The therapeutic potential of the labdane diterpenoid forskolin","author":"Salehi","year":"2019","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejphar.2025.178182_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.178182_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005465","article-title":"YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers","volume":"11","author":"Stein","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2025.178182_bib45","doi-asserted-by":"crossref","DOI":"10.3791\/52438-v","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","author":"Tag","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejphar.2025.178182_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-023-01979-1","article-title":"New therapies on the horizon for primary biliary cholangitis","volume":"84","author":"Tanaka","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.178182_bib47","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178182_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/j.gastro.2020.10.035","article-title":"Regeneration defects in Yap and taz mutant mouse livers are caused by bile duct disruption and cholestasis","volume":"160","author":"Verboven","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178182_bib49","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178182_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01319-y","article-title":"Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma","volume":"9","author":"Wei","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.178182_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejphar.2025.178182_bib52","article-title":"LncRNA GAS5 knockdown mitigates hepatic lipid accumulation via regulating MiR-26a-5p\/PDE4B to activate cAMP\/CREB pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.178182_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-024-10177-5","article-title":"YAP\/TAZ as master regulators in liver regeneration and disease: insights into mechanisms and therapeutic targets","volume":"52","author":"Ye","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2025.178182_bib55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"World J. Hepatol."},{"issue":"96","key":"10.1016\/j.ejphar.2025.178182_bib56","first-page":"350","article-title":"Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes","volume":"963","author":"Zhang","year":"2015","journal-title":"Lab. Investig."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:32:43Z","timestamp":1780201963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"alternative-id":["S0014299925009367"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178182","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forskolin alleviates cholestatic liver disease by inhibiting the Hippo\/YAP-mediated ductular reaction and fibrosis progression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178182"}}